Building Respiratory Support in East Africa Through High Flow Versus Standard Flow Oxygen Evaluation

Recruiting N/A Interventional Study
Acute Hypoxemia
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
1,600 (estimated)
Sponsor
Beth Israel Deaconess Medical Center · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Acute hypoxemia is common and deadly in resource variable settings. While studies in high income countries (HICs) have indicated a possible benefit to high flow oxygen as compared with standard flow oxygen, rigorous studies in low or lower middle income countries (LMICs) have not been performed. Studies in sepsis have demonstrated that interventions that improve outcomes in one context may actuall…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * age\>=18 years AND * admitted to a study site hospital within the 24 hours prior to screening AND * SpO2\<90% at time of first assessment OR * receiving oxygen at time of first assessment Exclusion Criteria: * imminent death (high clinical suspicion of death within 24 hours …
Contacts

Elisabeth Riviello, MD, MPH

+1 617 447 5131

eriviell@bidmc.harvard.edu

CONTACT

Theogene Twagirumugabe, MD, PhD

+250 788 539 904

twagirumugabe@gmail.com

CONTACT